umityasarsinan1 Profile Banner
Ümit Yaşar Sinan, MD, FESC Profile
Ümit Yaşar Sinan, MD, FESC

@umityasarsinan1

Followers
3K
Following
5K
Media
388
Statuses
2K

Assoc. Prof. of Cardiology, İÜCKE Epidemiyolojik ve Prevantif Kardiyoloji AD Başkanı, ACVC Study Group APE, EHJ-ACVC Editorial Board, AJC SM Editor, ACHD CESEE

İstanbul, Türkiye
Joined October 2018
Don't wanna be here? Send us removal request.
@BirbenArda
Arda Birben
6 days
✍️
21
707
5K
@fenermarkajorg
Fener Markaj
6 days
"Bu ligin sportif gerçekliği yok. Maçlar sahada kazanılmıyor." - Jorge Jesus
76
1K
8K
@averajdigital
Averaj
6 days
Fırat Aydınus: "Pozisyon net penaltı"
13
53
332
@UmutKocabasMD
Umut Kocabaş
27 days
Türkiye’nin ilk süregen, ileriye dönük, çok merkezli ve bulut tabanlı kalp yetersizliği kayıt sistemi olan Türkiye Kalp Yetersizliği Kayıt Çalışması’nın gerekçe ve metodoloji sunumunu TKD Ulusal Kongresi kapsamında gerçekleştirdik. Emeği geçen tüm arkadaşlarıma teşekkür ederim.
0
3
12
@umityasarsinan1
Ümit Yaşar Sinan, MD, FESC
1 month
Sevenin halinden sevenler anlar 💙💛
@SportsCubuklu
Çubuklu Sports
1 month
💛 Sevenin halinden sevenler anlar. https://t.co/41ippMaOxC
0
0
0
@WGACHDChair
ESC WG on ACHD Chairperson
3 months
🌍 Global Perspectives on CHD 📍 Tbilisi | 🗓️ 31 Aug 11:00–12:00 #ESCCongress Joint session by #AEPC & #ISACHD Uniting global voices to rethink #CHD care! 🎙️ Chairs: K Prokselj 🇸🇮 | J S Dua 🇬🇧 | O Tutarel 🇩🇪 💡 Speakers: A Saxena 🇮🇳 G P Diller 🇩🇪 J Sabatino 🇮🇹 #ACHD
2
4
18
@emraherdoganmd
Doç. Dr. Emrah Erdoğan
3 months
#HOTLİNES #ESCCongress #WCCardio 🔥 DIGIT-HF RCT ✅Digitoxin in pts w HFrEF was safe ⬇️ comp of mortality or worsening of HF (%18 RR)@umityasarsinan1 @aayshacader @DrMarthaGulati @RaberLorenz @TKDsosyal @mirvatalasnag @mmamas1973 @ColletCarlos @escardio @MDuyguinan @cembarcin
0
7
12
@emraherdoganmd
Doç. Dr. Emrah Erdoğan
3 months
🔥 POTCAST Trial ⬆️K by 0.3 mol/l ⬇️primary comp. endpoint by %24 ( VT, hospitalisation, mortality) in ICD Patients @umityasarsinan1 @aayshacader @DrMarthaGulati #esccongress2025 @hect2701 @RaberLorenz @TKDsosyal @mirvatalasnag @mmamas1973 @ColletCarlos @escardio @scaganefe
0
5
16
@umityasarsinan1
Ümit Yaşar Sinan, MD, FESC
4 months
🚨 New publication in BMC CVD! “Long-term follow-up results of adult atrial septal defect population” 📊 416 adult ASD patients, >40 years follow-up ✅ Surgical or percutaneous closure → improved survival 📄 Read here: https://t.co/1NcX98UgUv #Cardiology #ACHD #ASD #Research
3
2
36
@WGACHDChair
ESC WG on ACHD Chairperson
4 months
💡 ACHD in Focus at ESC Congress 2025! 📍ESC Congress 2025 All days are packed with high-impact sessions on Adult Congenital Heart Disease #ACHD 🗓️ ACHD Highlights (Part 1): See below: 📌 Location: Madrid, ESC Congress (various venues) 🔗 https://t.co/8OhiOU4s77 #ESCCongress2025
1
7
22
@umityasarsinan1
Ümit Yaşar Sinan, MD, FESC
5 months
https://t.co/NR7zioxtz5 🚨 New publication! 📘 Reassessing Loop Diuretic Strategies in HFrEF: A Case for Preferential Torsemide Use? 👨‍⚕️ U.Y. Sinan, W.-C. Lee 🔗 https://t.co/hr1DJtEOuX 💬 Could torsemide be the better choice in HFrEF? #Cardiology #HFrEF #Torsemide #HeartFailure
Tweet card summary image
karger.com
Heart failure with reduced ejection fraction (HFrEF) remains a major contributor to morbidity and mortality worldwide, necessitating optimization of all therapeutic strategies, including diuretic...
0
0
9
@Fenerbahce
Fenerbahçe SK
5 months
Sarı lacivertin mirasıyla yeniden bir arada. ⭐️​ #BizeEmanet
4K
17K
106K
@AybukeGeylan
Aybüke Geylan, MD
7 months
It was a great pleasure to present in front of leading experts and colleagues from around the world! So much to learn from their expertise, grateful for the opporturnity! #HeartFailure2025
1
4
26
@WGACHDChair
ESC WG on ACHD Chairperson
8 months
💥 Eisenmenger Syndrome & Risk Stratification #ACHD #CHD Current risk models for Eisenmenger syndrome lack specificity. A new study reviews key predictors, emphasizing the need for improved stratification to enhance patient outcomes. 📖 Read more: https://t.co/ruprDF1hsy
1
26
47
@AybukeGeylan
Aybüke Geylan, MD
10 months
Excited to share that our case has been selected for the HFA Congress 2025! Can’t wait to connect with experts, share knowledge, and learn about the latest advancements! #HeartFailure2025
0
2
12
@umityasarsinan1
Ümit Yaşar Sinan, MD, FESC
10 months
Rezillik artık, diyecek bir şey bulamıyorum…
0
0
10
@UmutKocabasMD
Umut Kocabaş
11 months
The follow-up results of the ANATOLIA-AF Study has just been published in Clinical Cardiology 🥳 https://t.co/DbAG9fB41F I would like to thank to my colleagues for their contribution ❤️ @umityasarsinan1 @KivrakTar69719 @seldamurat_dr @Drbektas @veyselozgurbar1 @ardaguler
1
6
20
@umityasarsinan1
Ümit Yaşar Sinan, MD, FESC
11 months
📢 Excited to share our latest publication “Screening for Subclinical Atherosclerosis in Patients with Familial Hypercholesterolemia: 🔗 Read the full article here: https://t.co/8SLxpxkd6v Special thanks to all co-authors and contributors! #FH #Atherosclerosis #Cardiology
Tweet card summary image
mdpi.com
Background/Objectives: Familial hypercholesterolemia (FH) is a monogenic dyslipidemia that leads to early cardiovascular events.
1
1
12
@AybukeGeylan
Aybüke Geylan, MD
11 months
Geride bıraktığımız yıldan klinik yaklaşımımızı etkileyecek çalışmaları konuştuğumuz son CardioRadio bölümü yayında! 🎙️
0
7
21